R&D financing by “SNN” and “Province Groningen”

September 27, 2017

HaemoScan continuously attempts to improve (international) biomedical standards and measurement techniques by researching and developing alternative methods. Such projects are partially financed by the Dutch organization “Samenwerkingsverband Noord-Nederland” (SNN) as part of the “Koers Noord” program, as well as by the province Groningen as part of the “Innovatief Actieprogramma Groningen-4”.   […]


ISO 9001 – Successfully prolonged until 2018!

January 15, 2016

HaemoScan B.V. is proud to announce that it is re-certified for a second period of three years. In December 2015 the quality management system of HaemoScan was audited by DNV-GL and found to be in compliance with the ISO 9001:2008 standard. In the next period, HaemoScan will adjust and improve […]


New ELISA for the brain injury marker

September 26, 2011

We have developed a new compatitve ELISA for the new brain injury marker Neuroketal. Neuroketal is thought to be a highly specific marker for (oxidative) brain injury and can cause brain injury by itself. Neuroketal can be measured in either serum, plasma or urine. For more background information about Neuroketal, […]